The United States underscored Friday its opposition to a new European Union plan to allow member states to block genetically engineered imports after bilateral talks on a transatlantic free-trade pact.
“It is hard to square this proposal with either EU long-standing internal obligations or their aspiration for a seamless internal market,” said Dan Mullaney, the assistant U.S. trade representative for Europe and the Middle East.
“We are still studying the proposal implications but we hope that the EU will move forward in a way that respects our decades-old rules on trade,” he added.
Mullaney was speaking at a news conference following the ninth round of U.S.-EU trade negotiations on the Transatlantic Trade and Investment Partnership held this week in New York. Click here to read more.